AVITA Medical, Inc. (RCEL) Change in Receivables (2019 - 2025)

AVITA Medical (RCEL) has reported Change in Receivables for 7 consecutive years, with -$81000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables rose 94.56% year-over-year to -$81000.0; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 187.65% YoY), and the FY2025 full-year result was $3.6 million, up 187.65% from the prior year.
• Change in Receivables fell to -$81000.0 in Q4 2025 per RCEL's latest filing, from $2.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $2.3 million in Q3 2025 and bottomed at -$1.7 million in Q4 2023.
• Historically, Change in Receivables has averaged -$409705.9 across 5 years, with a median of -$362000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Receivables plunged 4481.82% in 2024, then soared 254.83% in 2025.
• Over 5 years, Change in Receivables stood at -$1.2 million in 2021, then jumped by 192.73% to $1.1 million in 2022, then slumped by 253.06% to -$1.7 million in 2023, then gained by 12.36% to -$1.5 million in 2024, then jumped by 94.56% to -$81000.0 in 2025.
• According to Business Quant data, Change in Receivables over the past three periods registered -$81000.0, $2.3 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.